Bristol-myers Squibb Compnay

Ashok Kumar Adisechan

James A Johnson

Heather J Finlay

John E Lloyd

Ji Jiang

Prashantha Gunaga

Abhisek Banerjee

James Neels

Srinivasu Pothukanuri

Naveen Kumar Dhondi

Pothukanuri Srinivasu

Kavitha Govindrajulu

Govindrajulu Kavitha

A compound of formula (I) (I) wherein A, R1, R1a, R3 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function. 

Isoquinolines as potassium ion channel inhibitors

A compound of formula (I) wherein A, R, R, and Rare described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment of arrhythmia, I-associated disorders, and other disorders mediated by ion channel function. 

Pyrrolopyridazines as potassium ion channel inhibitors

A compound of formula (I), wherein A, R, R, and Rare described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, I-associated disorders, and other disorders mediated by ion channel function. 

Pyrrolotriazines as potassium ion channel inhibitors

A compound of formula (I) wherein A, R, R, and Rare described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, I-associated disorders, and other disorders mediated by ion channel function.

Phthalazines as potassium ion channel inhibitors

A compound of formula (I) wherein A, R, R, and Rare described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment of arrhythmia, maintaining normal sinus rhythm, I-associated disorders, and other disorders mediated by ion channel function.

Growing community of inventors

Pondicherry, India

Ashok Kumar Adisechan